Neurogene Announces Successful Completion of Dosing in Embolden(TM) Registrational Trial of NGN-401 for Rett Syndrome
June 8, 2026
Pharmaceuticals
-
-
Trulieve Announces Uplist to NYSE
June 5, 2026
-
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
-
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
June 1, 2026
-
Glass House Brands Completes Previously Announced Warrant Redemption
May 29, 2026
-
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
May 13, 2026
-
Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders
May 13, 2026
-
Rubicon Organics Obtains Key Certification for International Export at Cascadia Facility
May 11, 2026
-
Assertio Announces Amended and Restated Merger Agreement with Garda Therapeutics
May 4, 2026
-
Vireo Growth to Acquire FLUENT in All-Stock Transaction
April 30, 2026
-
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
April 23, 2026
-
Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants
April 17, 2026
-
iAnthus Expands Florida Footprint with new Dispensary Presence in Jupiter, FL
April 17, 2026
-
Decibel Reports Full-Year and Fourth Quarter 2025 Results: Revenue Grows 22% to $113 Million, Issues 2026 Guidance
April 16, 2026
-
LEEF Brands Announces Acquisition of HIMALAYA, a Leading California Concentrates Brand, to Expand Vertical Integration and Drive Margin Expansion
April 16, 2026
-
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform
April 15, 2026